These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2934487)

  • 1. Host-parasite interaction in relation to leprosy.
    Mahadevan PR
    Indian J Lepr; 1985; 57(2):239-57. PubMed ID: 2934487
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intercellular relations in the immunology of leprosy].
    Hoffenbach A
    Acta Leprol; 1986; 4(3):323-9. PubMed ID: 2951961
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin-2-induced T-cell response to M. leprae in lepromatous leprosy: reversion of a suppressor mechanism or expansion of a small M. leprae-reactive T-cell pool?
    Shankar P; Wallach D; Bach MA
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):649-52. PubMed ID: 2935587
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of interleukin-1 (IL-1) and IL-2 on lymphocytes from patients with leprosy.
    Rada EM; Mosco W; Aranzazu N; Convit J
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):351-3. PubMed ID: 3298481
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigations related to the development of a leprosy vaccine.
    Convit J; Aranzazu N; Ulrich M; Zúñiga M; de Aragón ME; Alvarado J; Reyes O
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):531-9. PubMed ID: 6231259
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.
    Nath I; Van Rood JJ; Mehra NK; Vaidya MC
    Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early events in the host-parasite relationship and immune response in clinical leprosy: its possible importance for leprosy control.
    Bjune G; Closs O; Barnetson RS
    Clin Exp Immunol; 1983 Nov; 54(2):289-97. PubMed ID: 6228348
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological aspects of human leprosy.
    Nath I
    Lepr India; 1983 Oct; 55(4):752-62. PubMed ID: 6230487
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypothesis: do phases of immunosuppression during a Mycobacterium leprae infection determine the leprosy spectrum?
    Stoner GL
    Lepr Rev; 1981 Mar; 52(1):1-10. PubMed ID: 6454034
    [No Abstract]   [Full Text] [Related]  

  • 10. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG.
    Rada EM; Convit J; Ulrich M; Gallinotto ME; Aranzazu N
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):646-50. PubMed ID: 2963084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impressions on the expression of suppression in leprosy.
    Godal T; Mustafa AS; Haregewoin A
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):510-4. PubMed ID: 6231258
    [No Abstract]   [Full Text] [Related]  

  • 14. Fate of Mycobacterium leprae in macrophages of patients with lepromatous or tuberculoid leprosy.
    Godal T; Rees RJ
    Int J Lepr Other Mycobact Dis; 1970; 38(4):439-42. PubMed ID: 4929374
    [No Abstract]   [Full Text] [Related]  

  • 15. Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria.
    Convit J; Pinardi ME; Rodríguez Ochoa G; Ulrich M; Avila JL; Goihman M
    Clin Exp Immunol; 1974 Jun; 17(2):261-5. PubMed ID: 4619359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
    Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular growth of an obligatory parasite mycobacterium leprae. Host bacterial interactions.
    Talwar GP; Krishnan AD; Jha P; Mehra V
    Biochimie; 1974; 56(2):231-7. PubMed ID: 4135832
    [No Abstract]   [Full Text] [Related]  

  • 18. Leprosy vaccine.
    Newmark P
    Microbiol Sci; 1984 Jun; 1(3):78-9. PubMed ID: 6242878
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
    Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
    J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of T-cell unresponsiveness in leprosy.
    Bach MA; Hoffenbach A; Lagrange PH; Wallach D; Cottenot F
    Ann Immunol (Paris); 1983; 134D(1):75-84. PubMed ID: 6226239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.